TLV •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 12:11
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTLV
Market Capitalization300.16 mln
Float638 mln
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
-1.57
Negative equity
ROE
-3,788
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Bonus BioGroup is an Israel-based biotechnology company focused on developing treatments that use the body's own cells and tissues to heal damage and disease. Its two main products are BonoFill, which aims to regenerate bone in patients with jaw or limb defects and osteoporosis, and MesenCure, designed to treat severe lung complications from COVID-19 as well as conditions such as kidney disease and arthritis. Both products are currently being tested in clinical trials. Founded in 1981 and headquartered in Haifa, the company was previously known as Oceana Advanced Industries Ltd.
